Sup. Figure 8: Foretinib treatment was feasible in the liver metastasis and brain metastasis-mimicking models obtained using KM12SM-ER cells. from Foretinib Overcomes Entrectinib Resistance Associated with the <i>NTRK1</i> G667C Mutation in <i>NTRK1</i> Fusion–Positive Tumor Cells in a Brain Metastasis Model

Abstract

<p>Body weights of treated mice in the (A) liver metastasis model (Fig. 5) and (B) brain metastasis-mimicking model (Fig. 6) were evaluated.</p>